Products - Allergies and anaphylaxis | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

12 SQ-HDM SLIT for treating allergic rhinitis caused by house dust mites in children 5 to 11 years ID6510
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 August 2026
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years ID6537
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 August 2026
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines ID6356
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Pharmalgen for the treatment of bee and wasp venom allergy
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
9 January 2026
Expected publication date:
TBC